Diversified healthcare company providing health insurance and healthcare services through UnitedHealthcare and Optum divisions.
Profile & Fundamentals
UnitedHealth Group Incorporated: Company identity, ownership, reported financial performance, balance sheets, and corporate actions.
Profile & Fundamentals
UnitedHealth Group Incorporated Profile & Fundamentals
Examine company identity, ownership, reported performance, valuation, balance-sheet resilience, dividends, buybacks, and material corporate events.
Explore this pageJump to a Profile & Fundamentals section
Explore this research
Profile & Fundamentals contents
Jump directly to any section
Company and Market Context
Company Profile & Ownership
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; Medicaid plans, including Temporary Assistance to Needy Families; Children's Health Insurance Programs; Dual SNPs; Long-Term Services and Supports; Aged, Blind and Disabled; and other federal, state, and community health care programs. and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.
Company profile record
UnitedHealth Group Incorporated
Common Stock · Health Care · Managed Health Care
Company
- Company / asset
- UnitedHealth Group Incorporated
- Security type
- Common Stock
- Sector
- Health Care
- Industry
- Managed Health Care
- HQ
- 🇺🇸 United States
- Head office
- 1 Health Drive, Eden Prairie, MN, United States, 55344
Leadership & scale
- Chief executive
- Mr. Stephen J. Hemsley
- CEO year born
- 1953
- Full-time employees
- 390K
- Fiscal year end
- December
- IPO date
- 1984-10-26
Fundamentals snapshot
- Market Cap
- USD 340.9B
- P/E
- 24.1x
- Revenue (Q2 26)
- USD 112.0B
- Profit (Q2 26)
- USD 5.5B
- Dividend Yield
- 2.1%
- Revenue (FY 25)
- USD 447.6B
- Shares in public float
- 895M
- Insider ownership
- 0.25%
Reporting & identifiers
- Symbol
- UNH.NYSE
- Listing
- 🇺🇸 United States | Dividend Tax: 30%
- Ticker Currency
- USD
- Income Statement Currency
- USD
- Balance Sheet Currency
- USD
- Cash Flow Currency
- USD
- EPS Currency
- USD
- Contract Type
- SPOT
- ISIN
- US91324P1021
- Asset ID
- equity_fa46c8b3-24ec-594c-b682-1f81d7c0a065
Ownership
Shares Outstanding
Latest: 906.0M | Max: 991.0M | Min: 906.0M
Latest reported ownership snapshot
As of Oct 1, 2026Float Shares
98.79%
895.0M latest reported shares
Insider Ownership
0.25%
Latest reported insider stake
Short Float
0.02%
Latest reported short interest / float
Top Holders
Source tablesView ownership tables
Shares Outstanding
Annual reported shares outstanding; up to 10 reporting dates.
Scroll the table to see every column.
| Reporting date | Shares outstanding |
|---|---|
| 2017-01-01 | 991,000,000 |
| 2018-01-01 | 982,000,000 |
| 2019-01-01 | 962,000,000 |
| 2020-01-01 | 961,000,000 |
| 2021-01-01 | 955,000,000 |
| 2022-01-01 | 947,000,000 |
| 2023-01-01 | 935,000,000 |
| 2024-01-01 | 927,000,000 |
| 2025-01-01 | 910,000,000 |
| 2026-01-01 | 906,000,000 |
Top Holders
Available reported ownership records.
Scroll the table to see every column.
| Holder | Shares | Ownership | Reported date |
|---|---|---|---|
| BlackRock Inc | 73,467,531 | 8.18% | 2026-03-31 |
| Vanguard Capital Management, LLC | 58,870,777 | 6.56% | 2026-03-31 |
| State Street Corp | 45,332,186 | 5.05% | 2026-03-31 |
| Capital World Investors | 29,887,932 | 3.33% | 2026-06-30 |
| Vanguard MStar Total Stk Mkt Idx Invest | 28,860,807 | 3.22% | 2026-08-31 |
| Vanguard 500 Index Investor | 24,125,809 | 2.69% | 2026-08-31 |
| Vanguard Portfolio Management, LLC | 24,036,504 | 2.68% | 2026-03-31 |
| Geode Capital Management, LLC | 22,768,695 | 2.54% | 2026-03-31 |
| T. Rowe Price Associates, Inc. | 20,873,946 | 2.33% | 2026-03-31 |
| Charles Schwab Investment Management Inc | 20,817,755 | 2.32% | 2026-03-31 |
| JPMorgan Chase & Co | 19,102,541 | 2.13% | 2026-03-31 |
| Morgan Stanley - Brokerage Accounts | 14,963,569 | 1.67% | 2026-03-31 |
| NORGES BANK | 12,736,973 | 1.42% | 2026-06-30 |
| iShares Core S&P 500 ETF | 12,093,349 | 1.35% | 2026-08-31 |
| FMR Inc | 12,019,046 | 1.34% | 2026-03-31 |
Earnings, Profitability & Valuation
Earnings, Profitability & Valuation
Earnings & Revenue
Earnings and Revenue Trajectory
AI Review
UnitedHealth's financial performance demonstrates a clear recovery after absorbing extreme operational headwinds in 2025. During that difficult year, operating income fell over forty percent despite double-digit revenue gains, squeezed by surging surgical claims and major cyberattack disruptions. First-half 2026 results confirm that management's aggressive contract repricing and cost controls have successfully arrested that profit decline. Recent quarterly net income rebounded sharply toward five point five billion dollars, while trailing free cash flow recovered to twenty-three point six billion dollars. The top-line revenue slowdown is intentional, reflecting deliberate contract exits to eliminate money-losing coverage. This strategic pivot from volume growth to profit discipline restores sustainable cash generation.
UnitedHealth's financial performance demonstrates a clear recovery after absorbing extreme operational headwinds in 2025. During that difficult year, operating income fell over forty percent despite double-digit revenue gains, squeezed by surging surgical claims and major cyberattack disruptions. First-half 2026 results confirm that management's aggressive contract repricing and cost controls have successfully arrested that profit decline. Recent quarterly net income rebounded sharply toward five point five billion dollars, while trailing free cash flow recovered to twenty-three point six billion dollars. The top-line revenue slowdown is intentional, reflecting deliberate contract exits to eliminate money-losing coverage. This strategic pivot from volume growth to profit discipline restores sustainable cash generation.
Revenue, Net Income, and Free Cash Flow
Latest: USD 447.6B | Max: USD 447.6B | Min: USD 7.0B
Valuation
P/E Ratio (TTM)iPublished valuation snapshots use the earnings basis recorded with each observation. Source tables retain that basis.
Latest: 25x
Profitability & Margins
Margins and Operating Efficiency
AI Review
Profitability margins suffered an unprecedented squeeze in 2024 and 2025, with consolidated operating margins falling from over eight percent to four point two percent. This margin decay was primarily driven by higher outpatient medical care ratios and Medicare risk-coding payment adjustments that temporarily outpaced annual insurance premium pricing. Evidence from 2026 indicates that this margin compression was a cyclical pricing delay rather than permanent damage. As revised commercial rates take effect and unprofitable accounts expire, operating margins have rebounded above seven percent. Supported by Optum's high-margin healthcare services, enterprise profitability is steadily stabilizing within a healthy, sustainable long-term corridor.
Profitability margins suffered an unprecedented squeeze in 2024 and 2025, with consolidated operating margins falling from over eight percent to four point two percent. This margin decay was primarily driven by higher outpatient medical care ratios and Medicare risk-coding payment adjustments that temporarily outpaced annual insurance premium pricing. Evidence from 2026 indicates that this margin compression was a cyclical pricing delay rather than permanent damage. As revised commercial rates take effect and unprofitable accounts expire, operating margins have rebounded above seven percent. Supported by Optum's high-margin healthcare services, enterprise profitability is steadily stabilizing within a healthy, sustainable long-term corridor.
Profitability Margins
Latest: 18.5% | Max: 26.1% | Min: 2.7%
Latest Profitability Ratios as of 2025-12-31
Gross Margin
18.5%
Gross profit / revenue
Operating Margin
4.2%
Operating income / revenue
Net Margin
2.7%
Net income / revenue
FCF Margin
3.6%
Free cash flow / revenue
Source tablesView earnings, profitability & valuation tables
Revenue, Net Income, and Free Cash Flow
Annual reported results, using the source statement's recorded USD conversion. Up to 10 reporting periods; missing values are not estimated.
Scroll the table to see every column.
| Period end | Revenue (USD) | Net income (USD) | Free cash flow (USD) |
|---|---|---|---|
| 2016-12-31 | 184,840,000,000 | 7,017,000,000 | 8,090,000,000 |
| 2017-12-31 | 201,159,000,000 | 10,558,000,000 | 11,573,000,000 |
| 2018-12-31 | 226,247,000,000 | 11,986,000,000 | 13,650,000,000 |
| 2019-12-31 | 242,155,000,000 | 13,839,000,000 | 16,392,000,000 |
| 2020-12-31 | 257,141,000,000 | 15,403,000,000 | 20,123,000,000 |
| 2021-12-31 | 287,597,000,000 | 17,285,000,000 | 19,889,000,000 |
| 2022-12-31 | 324,162,000,000 | 20,120,000,000 | 23,404,000,000 |
| 2023-12-31 | 371,622,000,000 | 22,381,000,000 | 25,682,000,000 |
| 2024-12-31 | 400,278,000,000 | 14,405,000,000 | 20,705,000,000 |
| 2025-12-31 | 447,567,000,000 | 12,056,000,000 | 16,075,000,000 |
Published P/E Ratio
Published valuation snapshots retain each observation's earnings basis.
Scroll the table to see every column.
| Period end | P/E (times earnings) | Earnings basis |
|---|---|---|
| 2025-12-31 | 24.92 | Trailing four quarters |
| 2024-12-31 | 32.55 | Trailing four quarters |
| 2023-12-31 | 21.99 | Trailing four quarters |
| 2022-12-31 | 24.95 | Annual net income |
| 2021-12-31 | 27.74 | Annual net income |
Profitability Margins
Matching annual reporting dates. Values are percentages.
Scroll the table to see every column.
| Period end | Gross margin (%) | Operating margin (%) | Net margin (%) | Free cash flow margin (%) |
|---|---|---|---|---|
| 2016-12-31 | 23.47 | 7 | 3.8 | 4.38 |
| 2017-12-31 | 23.37 | 7.56 | 5.25 | 5.75 |
| 2018-12-31 | 23.8 | 7.67 | 5.3 | 6.03 |
| 2019-12-31 | 23.79 | 8.13 | 5.71 | 6.77 |
| 2020-12-31 | 26.06 | 8.71 | 5.99 | 7.83 |
| 2021-12-31 | 24.22 | 8.33 | 6.01 | 6.92 |
| 2022-12-31 | 24.56 | 8.77 | 6.21 | 7.22 |
| 2023-12-31 | 24.48 | 8.71 | 6.02 | 6.91 |
| 2024-12-31 | 22.33 | 8.07 | 3.6 | 5.17 |
| 2025-12-31 | 18.53 | 4.24 | 2.69 | 3.59 |
Public data excerpt created by iPulse AI and published by Future Edge Group FZE. Source: eodhd. Snapshot retrieved 2026-10-01.
Use is subject to the iPulse AI Terms of Service and applicable source rights. Missing inputs are not estimated. Full access includes the remaining records, research and interactive tools.
Complete Research Workspace
Unlock the complete Profile & Fundamentals
Sign in to verify your access, or upgrade to the Base plan to open the complete profile & fundamentals and available source data.